Shire PLC American Deposit Receipt Represen (SHPGY) Stock Quote ...
Get the latest SHPGY - Shire PLC American Deposit Receipt Represen stock market performance data and financial news.
Shire PLC American Deposit Receipt Represen (SHPGY) Community ...
Get the latest SHPGY - Shire PLC American Deposit Receipt Represen together with stock market performance data and financial news.
Jim Cramer's Take on Shire PLC American Deposit Receipt Represen ...
Read Jim Cramer's take on Shire PLC American Deposit Receipt Represen (SHPGY) and get his latest thoughts on the company?s performance and outlook
Shire PLC American Deposit Receipt Represen (SHPGY) Stock Quote ...
Get the latest SHPGY - Shire PLC American Deposit Receipt Represen stock market performance data and financial news.
Financial Portfolio on Recent Stock Quotes & Stock Market Picks ...
Stock portfolio management made easy with updated quotes, investing tools and financial advice. TheStreet is the source for financial market and Wall Street news, trading stock and personal finance advice.
Shire to Take on Genzyme With Gaucher Drug
Shire will seek U.S. regulatory approval for its Gaucher drug following the release of positive phase III study results.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10561164/1/shire-to-take-on-genzyme-with-gaucher-drug.html
Genzyme Shares Rise on FDA Panel Nod
An FDA panel has unanimously recommended approval of a single-dose version of Synvisc, already approved for three-dose use.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10452472/1/genzyme-shares-rise-on-fda-panel-nod.html
Thursday's Health Winners & Losers
Chelsea rises.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10332072/1/thursdays-health-winners-losers.html
Shire Colitis Drug Approved
Lialda is a once-a-day treatment.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/newsanalysis/pharmaceuticals/10332896.html
Transkaryotic Gets Enough Shareholder Support
The company says 52.6% of the eligible voting shares agree with the merger plan.. Check out TheStreet for the latest stock market news and financial investment headlines.
http://www.thestreet.com/story/10235094/1/transkaryotic-gets-enough-shareholder-support.html
Connect with TheStreet